Unknown

Dataset Information

0

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.


ABSTRACT: The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.

SUBMITTER: Wrobel AG 

PROVIDER: S-EPMC7577971 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.

Wrobel Antoni G AG   Benton Donald J DJ   Hussain Saira S   Harvey Ruth R   Martin Stephen R SR   Roustan Chloë C   Rosenthal Peter B PB   Skehel John J JJ   Gamblin Steven J SJ  

Nature communications 20201021 1


The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike. ...[more]

Similar Datasets

| S-EPMC7091851 | biostudies-literature
| S-EPMC7252579 | biostudies-literature
| S-EPMC8581954 | biostudies-literature